Price$156.17+15.56 (+11.07%)
2026-03-042026-06-05
News · 26 weeks59-70%
2025-12-142026-06-07
Mix1890d
- Other5(28%)
- Insider5(28%)
- SEC Filings5(28%)
- Earnings2(11%)
- Analyst1(6%)
Latest news
25 items- INSIDERChief Executive Officer Glastra Matthijs sold $1,096,273 worth of shares (6,500 units at $168.66) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 36,261 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
- SECNovanta Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - NOVANTA INC (0001076930) (Filer)
- SECSEC Form SD filed by Novanta Inc.SD - NOVANTA INC (0001076930) (Filer)
- SECNovanta Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - NOVANTA INC (0001076930) (Filer)
- PRNovanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine and manufacturing, medical solutions, and robotics and automation with a proven ability to solve complex technical challen
- PRNovanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability t
- INSIDERChief Executive Officer Glastra Matthijs sold $1,128,244 worth of shares (7,500 units at $150.43) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 42,761 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
- SECSEC Form 10-Q filed by Novanta Inc.10-Q - NOVANTA INC (0001076930) (Filer)
- SECNovanta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - NOVANTA INC (0001076930) (Filer)
- PRNovanta Announces Financial Results for the First Quarter 2026First Quarter 2026 GAAP Revenue increased 10% to $258 million First Quarter 2026 GAAP Net Income was $21 million, and Adjusted EBITDA increased 14% to $57 million First Quarter 2026 GAAP Diluted EPS was $0.51, and Adjusted Diluted EPS increased 9% to $0.81 Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2026. Financial Highlights Three Months Ended (In millions, except per share amounts) April 3, March 28, 2026 2025
- INSIDERChief Executive Officer Glastra Matthijs sold $852,348 worth of shares (6,500 units at $131.13) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 50,261 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
- SECSEC Form DEF 14A filed by Novanta Inc.DEF 14A - NOVANTA INC (0001076930) (Filer)
- INSIDERSEC Form 4 filed by Glastra Matthijs4 - NOVANTA INC (0001076930) (Issuer)
- PRNovanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference CallNovanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2026 results after the close of U.S. financial markets on Monday, May 11, 2026. The Company will host a conference call on Tuesday, May 12, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hou
- ANALYSTNovanta upgraded by Robert W. Baird with a new price targetRobert W. Baird upgraded Novanta from Neutral to Outperform and set a new price target of $144.00
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Novanta Inc.SCHEDULE 13G/A - NOVANTA INC (0001076930) (Subject)
- INSIDERSEC Form 4 filed by Buckley Robert4 - NOVANTA INC (0001076930) (Issuer)
- PRNovanta Joins NVIDIA Halos AI Systems Inspection LabNovanta Inc. (NASDAQ:NOVT) announced today that it has joined NVIDIA Halos AI Systems Inspection Lab, the first ANSI National Accreditation Board (ANAB) accredited inspection lab for AI-driven physical systems. The lab helps accelerate certification and advance trust in key components and subsystems enabling the next generation of robotics and physical AI systems. By participating in Halos AI Systems Inspection Lab, Novanta will work with NVIDIA to validate the interoperability of our motion control and sensing technologies with safety requirements of NVIDIA platforms, including NVIDIA IGX Thor. This collaboration is designed to streamline the adoption of critical technology solutions to
- INSIDERChief Executive Officer Glastra Matthijs sold $899,239 worth of shares (6,500 units at $138.34), decreasing direct ownership by 9% to 63,261 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
- INSIDERCo-Chief Operating Officer Ravetto Charles Guy Jr converted options into 825 shares and covered exercise/tax liability with 243 shares, increasing direct ownership by 4% to 16,116 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
- INSIDERChief Financial Officer Buckley Robert converted options into 5,426 shares and covered exercise/tax liability with 2,624 shares, increasing direct ownership by 3% to 96,616 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
- INSIDERChief Accounting Officer Burke John Joseph Ii converted options into 479 shares and covered exercise/tax liability with 141 shares, increasing direct ownership by 4% to 8,900 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
- INSIDERChief Executive Officer Glastra Matthijs converted options into 10,852 shares and covered exercise/tax liability with 5,247 shares, increasing direct ownership by 9% to 69,761 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
- INSIDERChief Accounting Officer Burke John Joseph Ii converted options into 519 shares and covered exercise/tax liability with 176 shares, increasing direct ownership by 4% to 8,562 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
- INSIDERCo-Chief Operating Officer Ravetto Charles Guy Jr converted options into 1,059 shares and covered exercise/tax liability with 311 shares, increasing direct ownership by 5% to 15,534 units (SEC Form 4)4 - NOVANTA INC (0001076930) (Issuer)
NOVT FAQ
6 questionsWhat does Novanta Inc. do?
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The company's Vision...Where does NOVT stock trade?
Novanta Inc. (NOVT) is listed on NASDAQ.What sector and industry is NOVT in?
Novanta Inc. operates in the Miscellaneous sector, Industrial Machinery/Components industry.What are analysts saying about NOVT?
Novanta Inc. has had 2 recent analyst actions on file. The most recent action was from Robert W. Baird: Outperform on 2026-03-30.What companies are similar to NOVT?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), DE (Deere & Company), ETN (Eaton Corporation PLC). Compare NOVT side-by-side with any of them on Quantisnow.How can I track NOVT on Quantisnow?
Quantisnow aggregates Novanta Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NOVT to receive live email and push alerts on every new disclosure.